Charles River Laboratories International (CRL) Other financing activities (2009 - 2025)

Charles River Laboratories International's Other financing activities history runs 17 years deep, the most recent figure standing at -$1.3 million for Q4 2025.

• In Q4 2025, Other financing activities fell 102.63% year-over-year to -$1.3 million; the TTM figure through Dec 2025 stood at -$14.0 million (down 158.72% YoY), while the FY2025 annual figure was -$14.0 million, down 158.72% from the prior year.
• Other financing activities for Q4 2025 stood at -$1.3 million, up from -$12.7 million in the prior quarter.
• The five-year high for Other financing activities was $50.8 million in Q4 2024, with the low at -$38.3 million in Q4 2021.
• The 5-year median for Other financing activities is -$2.2 million (2024), against an average of -$120588.2.
• Peak annual rise in Other financing activities reached 818.79% in 2021, while the deepest fall reached 543.23% in 2021.
• Charles River Laboratories International's Other financing activities stood at -$38.3 million in 2021, then jumped by 33.41% to -$25.5 million in 2022, then surged by 83.73% to -$4.1 million in 2023, then surged by 1325.04% to $50.8 million in 2024, then sank by 102.63% to -$1.3 million in 2025.
• Business Quant data shows CRL's Other financing activities at -$1.3 million in Q4 2025, -$12.7 million in Q3 2025, and $1000.0 in Q2 2025.